Head and neck cancers: A clinico-pathological profile and management challenges in a resource-limited setting

BMC Research Notes

Volumn 8, Issue 1, 2015, Pages

  Gilyoma, Japhet M ^a   Rambau, Peter F ^a   Masalu, Nestory ^a   Kayange, Neema M ^a   Chalya, Phillipo L ^a  

^a CATHOLIC UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

Challenges; Clinicopathological; Head and neck cancers; Resource limited setting; Tanzania

Indexed keywords

ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHILD; COMORBIDITY; FEMALE; HEAD AND NECK NEOPLASMS; HEALTH CARE PLANNING; HIV INFECTIONS; HOSPITAL; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATHOLOGY; PRESCHOOL CHILD; PROCEDURES; RETROSPECTIVE STUDY; STANDARDS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TANZANIA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; HEAD AND NECK NEOPLASMS; HEALTH RESOURCES; HIV INFECTIONS; HOSPITALS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; TANZANIA; YOUNG ADULT;

EID: 84949940594     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/s13104-015-1773-9     Document Type: Article

References (39)

1. Pai SI, Westra WH. Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Ann Rev Pathol. 2009;4:49-70.
2. Nwawolo CC, Ajekigbe AT, Oyeneyin JO, Nwankwo KC, Okeowo PA. Pattern of head and neck cancers among Nigerians in Lagos. West Afi' J Med. 2001;20:111-6.
3. Fan CY. Epigenetic alterations in head and neck cancer: prevalence, clinical significance, and implications. Curr Oncol Rep. 2004;6:152-61.
4. Ringström E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT. Molecular oncology, markers, clinical correlates. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res. 2002;8:3187-92.
5. Otoh EC, Johnson NW, Danfillo IS, Adeleke OA, Olasoji HA. Primary head and neck cancer in North Eastern Nigeria. West Afr J Med. 2004;23:305-13.
6. Garfinkel L. Perspective on cancer prevention. Cancer J Clin. 1995;45:5-9.
7. Tobias JS. Cancer of the head and neck. BMJ. 1994;308:961-6.
8. Zagar GK, Smith JL, Norante JD, McDonald S. Tumours of the head and neck. In: Rubin P, editor. Clinical oncology: a multidisciplinary approach for physicians and students. 7th ed. Baltimore: W. B. Saunders; 1993. p. 319-62.
9. Watkinson JC, Gaze MN, Wilson JA. The nature of head and neck cancer. In: Watkinson JC, Gaze MN, Wilson JA, editors. Stella and Maran's head and neck surgery, 4th ed. Oxford: Butterworth Heinemann; 2000. p. 1-9.
10. Sanghvi LD, Rao DN, Joshi S. Epidemiology of head and neck cancer. Semin Surg Oncol. 1989;5:305-9.
11. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun M. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-30.
12. Lilly-Tariah OB, Somefun AO, Adeyemo WL. Current evidence on the burden of head and neck cancers in Nigeria. Head Neck Oncol. 2009;1:1-14.
13. Bhatia PL, Jha BK. Pattern of head and neck cancer in Maniour. Indian J Cancer. 1982;19:241-8.
14. Oude Ophuis MB, Roelofs HM, Van Den Brandt PA, Peters WH, Manni JJ. Polymorphisms of the glutathione S-transferase PI gene and head and neck cancer susceptibility. Head Neck. 2003;25:37-43.
15. Adeyemi BF, Adekunle LV, Kolude BM, Akang EEU, Lawoyin JO. Head and neck cancer - a clinicopathological study in a tertiary care centre. J Natl Med Assoc. 2008;100:690-7.
16. Ologe FE, Adeniji KA, Segun-Busari S. Clinicopathological study of head and neck cancers in Ilorin, Nigeria. Trop Doct. 2005;35:2-4.
17. Licitra L, Felip E, ESMO Guidelines Working Group. Squamous cell carcinoma of the head and neck: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20:121-2.
18. Deschamps DR, Spencer HJ, Kokoska MS, Spring PM, Vural EA, Stack BM. Implications of head and neck cancer treatment failure in the neck. Otolaryngology. 2010;142:722-7.
19. Onyango JF, Macharia IM. Delays in diagnosis, referral and management of head and neck cancer presenting at Kenyatta National Hospital, Nairobi. East Afr Med J. 2006;83:85-91.
20. Abdul-Hamid G, Saeed NM, Al-Kahiry W, Shukry S. Pattern of head and neck cancer in Yemen. Gulf J Oncol. 2010;7:21-4.
21. Decker J, Goldstein C. Current concepts in otolaryngology. Risk factors in head and neck cancers. N Engl J Med. 1982;306:1151-55.
22. Otoh EC, Johnson NW, Mandong BM, Danfillo IS. Primary head and neck cancers in Jos, Nigeria: a re-visit. West Afr J Med. 2006;25:92-100.
23. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. New Engl J Med. 1993;328:184-94.
24. Onotai LOI, Nwogbo AC. Primary head and neck malignant tumours in Port Harcourt, Nigeria: a revisit. J Med Med Sci. 2012;3:122-5.
25. Donkor P, Boateng KA. Prevalence of orofacial squamous cell carcinoma seen at Komfo Anokye Teaching Hospital. Ghana Med J. 2000;34:139-43.
26. Nwaorgu O, Kokong D, Onakoya P, Adoga S, Ibekwe T. Prevalence of human immunodeficiency virus seropositivity in head and neck malignancies in sub-Saharan Africa. Acta Oto-Laryngol. 2007;127:1218-21.
27. Ahmad BM, Pindiga UH. Malignant neoplasms of the ear, nose and throat in north eastern Nigeria. Highl Med Res J. 2004;2:45-8.
28. Iseh KR, Malami SA. Pattern of head and Neck cancers in Sokoto-Nigeria. Nig J Otolaryngol. 2006;3:77-83.
29. Amusa YB, Olabanji JK, Akinpelu VO, Ogundipe OV, Olateju S, Agbakwuru EA, Ndukwe N, Fatusi OA, Ojo OS. Pattern of head and neck malignant tumours in a Nigerian teaching hospital - a ten year review. West Afr J Med. 2004;23:280-5.
30. Haddad R, Annino D, Tishler RB. Multidisciplinary approach to cancer treatment focus on head/neck cancer. Dent Clin N Am. 2008;52:1-17.
31. Saboorian MH, Ashfaq R. The use of fine needle aspiration biopsy in the evaluation of lymphadenopathy. Semin Diagn Pathol. 2001;18:110-23.
32. Adoga AA, Silas OA, Nimkur TL. Open cervical lymph node biopsy for head and neck cancers: any benefit? Head Neck Oncol. 2009;1:9.
33. Hermans R. Head and neck cancer: how imaging predicts treatment outcome. Cancer Imaging. 2006;6:145-53.
34. Urassa M, Isingo R, Kumogola Y, Mwidunda P, Helelwa M, Changulucha J, Mngara J, Zaba B, Calleja T, Slaymaker E. Effect of PMTCT availability on choice of ANC in Mwanza and Magu districts and its impact on HIV sentinel surveillance in Tanzania, 2007 Report of ANC surveillance Mwanza and Magu Districts. 2007.
35. Adeyi A, Olugbenga S. The challenges of managing malignant head and neck tumors in a tropical tertiary health center in Nigeria. Pan Afr Med J. 2011;10:31.
36. Chrong N, Vokes E. Expanding role of the medical oncologist in the management of head/neck cancer. CA Cancer J C/M. 2008;58:32-53.
37. Kumar S, Pandey M, Lal P, Rastogi N, Maria Das KJ, Dimri K. Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial. Radiother Oncol. 2005;75:186-92.
38. Larsen-Reindorf R, Owusu-Afriyie O, Acheampong AO, Boakye I, Awuah B. A six-year review of head and neck cancers at the Komfo Anokye Teaching Hospital, Kumasi, Ghana. Int J Otolaryngol Head Neck Surg. 2014;3:271-8.
39. Gilbert H, Kagan AR. Recurrence patterns in squamous cell carcinoma of the oral cavity, pharynx, and larynx. J Surg Oncol. 1974;6:357-80.